These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33958861)

  • 1. Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity.
    Pyun JM; Ryu JS; Lee R; Shim KH; Youn YC; Ryoo N; Han SW; Park YH; Kang S; An SSA; Kim S
    Clin Interv Aging; 2021; 16():749-755. PubMed ID: 33958861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-β oligomerization data.
    Youn YC; Kim HR; Shin HW; Jeong HB; Han SW; Pyun JM; Ryoo N; Park YH; Kim S
    BMC Med Inform Decis Mak; 2022 Nov; 22(1):286. PubMed ID: 36344984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer's disease spectrum.
    Wang SM; Kang DW; Um YH; Kim S; Lee CU; Scheltens P; Lim HK
    Alzheimers Res Ther; 2024 Mar; 16(1):55. PubMed ID: 38468313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status.
    Babapour Mofrad R; Scheltens P; Kim S; Kang S; Youn YC; An SSA; Tomassen J; van Berckel BNM; Visser PJ; van der Flier WM; Teunissen CE
    Alzheimers Res Ther; 2021 Jul; 13(1):133. PubMed ID: 34311775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Oligomer β-Amyloid and White Matter Microstructural Integrity in Cognitively Normal Older Adults According to Cerebral Amyloid Deposition.
    Wang SM; Kang DW; Um YH; Kim S; Lee CU; Scheltens P; Lim HK
    J Prev Alzheimers Dis; 2023; 10(4):837-846. PubMed ID: 37874106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Amyloid-β Oligomerization as a Biomarker of Alzheimer's Disease: A Blinded Validation Study.
    Youn YC; Lee BS; Kim GJ; Ryu JS; Lim K; Lee R; Suh J; Park YH; Pyun JM; Ryu N; Kang MJ; Kim HR; Kang S; An SSA; Kim S
    J Alzheimers Dis; 2020; 75(2):493-499. PubMed ID: 32310175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer's disease.
    Meng X; Li T; Wang X; Lv X; Sun Z; Zhang J; Su F; Kang S; Kim S; An SSA; Yu X; Zhang C; Wang H
    Alzheimers Res Ther; 2019 Oct; 11(1):89. PubMed ID: 31651358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reference interval and the role of plasma oligomeric beta amyloid in screening of risk groups for cognitive dysfunction at health checkups.
    Nah EH; Cho S; Park H; Noh D; Hwang I; Cho HI
    J Clin Lab Anal; 2021 Sep; 35(9):e23933. PubMed ID: 34342379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease.
    Wang MJ; Yi S; Han JY; Park SY; Jang JW; Chun IK; Kim SE; Lee BS; Kim GJ; Yu JS; Lim K; Kang SM; Park YH; Youn YC; An SSA; Kim S
    Alzheimers Res Ther; 2017 Dec; 9(1):98. PubMed ID: 29246249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study.
    Pérez-Grijalba V; Arbizu J; Romero J; Prieto E; Pesini P; Sarasa L; Guillen F; Monleón I; San-José I; Martínez-Lage P; Munuera J; Hernández I; Buendía M; Sotolongo-Grau O; Alegret M; Ruiz A; Tárraga L; Boada M; Sarasa M;
    Alzheimers Res Ther; 2019 Dec; 11(1):96. PubMed ID: 31787105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous Aβ peptide promote Aβ oligomerization tendency of spiked synthetic Aβ in Alzheimer's disease plasma.
    Choi Y; Joh Y; Ryu JS; Kim K; Seo D; Kim S
    Mol Cell Neurosci; 2021 Mar; 111():103588. PubMed ID: 33422673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer's disease.
    Lin SY; Lin KJ; Lin PC; Huang CC; Chang CC; Lee YC; Hsiao IT; Yen TC; Huang WS; Yang BH; Wang PN
    Alzheimers Res Ther; 2019 Dec; 11(1):111. PubMed ID: 31881963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease.
    Xia W; Yang T; Shankar G; Smith IM; Shen Y; Walsh DM; Selkoe DJ
    Arch Neurol; 2009 Feb; 66(2):190-9. PubMed ID: 19204155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up Comparisons of Two Plasma Biomarkers of Alzheimer's Disease, Neurofilament Light Chain, and Oligomeric Aβ: A Pilot Study.
    Shim Y
    Curr Alzheimer Res; 2023; 20(10):715-724. PubMed ID: 38299421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer's disease.
    Youn YC; Kang S; Suh J; Park YH; Kang MJ; Pyun JM; Choi SH; Jeong JH; Park KW; Lee HW; An SSA; Dominguez JC; Kim S
    Alzheimers Res Ther; 2019 May; 11(1):40. PubMed ID: 31077246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis.
    Pyun JM; Youn YC; Park YH; Kim S
    Front Neurol; 2022; 13():1028448. PubMed ID: 36733444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
    Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
    Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma amyloid-beta oligomer is related to subjective cognitive decline and brain amyloid status.
    Kim KY; Park J; Jeong YH; Kim HJ; Lee E; Park JY; Kim E; Kim WJ
    Alzheimers Res Ther; 2022 Nov; 14(1):162. PubMed ID: 36324157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study.
    Pérez-Grijalba V; Romero J; Pesini P; Sarasa L; Monleón I; San-José I; Arbizu J; Martínez-Lage P; Munuera J; Ruiz A; Tárraga L; Boada M; Sarasa M
    J Prev Alzheimers Dis; 2019; 6(1):34-41. PubMed ID: 30569084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimer Detection System-Oligomerized Amyloid Beta (MDS-OA
    Dominguez JC; Yu JRT; De Guzman MF; Ampil E; Guevarra AC; Joson ML; Reandelar M; Martinez MS; Ligsay A; Ocampo F; Kim S
    Int J Alzheimers Dis; 2022; 2022():9960832. PubMed ID: 35547155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.